Alex Murray with Seres Therapeutics
GoodNature, a stool donation program from Seres Therapeutics, collects poop from healthy people and then studies the poop in hopes of advancing medical treatment options or potentially providing commercial therapies for gastrointestinal infections and disorders.
Seres Therapeutics’ mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. As a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, Seres is working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.
Seres has an exceptional team of drug development and microbiome experts. The leadership team, board of directors, and Scientific Advisory Board have vast experience in the discovery, development, regulatory approval, and successful commercialization of a wide range of therapeutic products.
Seres’ visionary team has been at the forefront of microbiome therapeutics for over a decade.For more information, please visit www.serestherapeutics.com. Seres Therapeutics ((Nasdaq: MCRB)
Alex Murray is the Vice President, Manufacturing and Supply Chain Operations at Seres Therapeutics. He’s an experienced leader with a demonstrated history of working in the pharmaceuticals industry and is skilled in delivering results through continuous improvement, technical transfers, and new facility start-ups.
Alex has more than twenty years of experience in the pharmaceutical industry and worked at GSK and Merck prior to joining Seres. He holds a BS in biomedical engineering with a chemical engineering concentration from Johns Hopkins University.
Follow GoodNature on LinkedIn, Facebook, Twitter and Instagram.
